EB1002   Click here for help

GtoPdb Ligand ID: 14664

Synonyms: compound ID 344 [ WO2023118263] | neurokinin A (4-10)-S5K/F6Y/L9mL/M10Mox | SEQ ID NO: 23 [WO2023118263]
Compound class: Peptide
Comment: EB1002 is a seven amino acid, chemically modified analogue of neurokinin A (NKA). It is reported as a NK2R selective agonist [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)C[C@@H](C(=O)N[C@@H](CCOC)C(=O)N)N(C)C(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O
Isomeric SMILES CC(C)C[C@@H](C(=O)N[C@@H](CCOC)C(=O)N)N(C)C(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O
InChI InChI=1S/C73H124N12O23/c1-49(2)43-58(71(100)81-53(67(75)96)32-36-104-6)85(5)63(91)46-78-72(101)66(50(3)4)84-70(99)56(44-51-26-28-52(86)29-27-51)83-68(97)54(23-21-22-33-74)82-69(98)57(45-65(94)95)80-62(90)48-108-42-40-106-38-35-77-61(89)47-107-41-39-105-37-34-76-59(87)31-30-55(73(102)103)79-60(88)24-19-17-15-13-11-9-7-8-10-12-14-16-18-20-25-64(92)93/h26-29,49-50,53-58,66,86H,7-25,30-48,74H2,1-6H3,(H2,75,96)(H,76,87)(H,77,89)(H,78,101)(H,79,88)(H,80,90)(H,81,100)(H,82,98)(H,83,97)(H,84,99)(H,92,93)(H,94,95)(H,102,103)/t53-,54-,55-,56-,57-,58-,66-/m0/s1
InChI Key SMIDDQXCMJFZEC-PPTFQZPPSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Ekberg JH, Christensen DP, Hansen JB. (2023)
Agonists for treatment of eating disorder.
Patent number: WO2023118263A1. Assignee: Embark Biotech ApS. Priority date: 21/12/2022. Publication date: 29/06/2023.
2. Sass F, Ma T, Ekberg JH, Kirigiti M, Ureña MG, Dollet L, Brown JM, Basse AL, Yacawych WT, Burm HB et al.. (2024)
NK2R control of energy expenditure and feeding to treat metabolic diseases.
Nature, 635 (8040): 987-1000. [PMID:39537932]